223
Views
33
CrossRef citations to date
0
Altmetric
Special Report

Influenza infection and vaccination in pregnant women

, &
Pages 321-328 | Published online: 09 Jan 2014

References

  • Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet374(9688), 451–458 (2009).
  • The ANZIC Influenza Investigators and Austalasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. Br. Med. J.340, c1279 (2010).
  • Hewagama S, Walker SP, Stuart RL et al. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin. Infect. Dis.50, 686–690 (2010).
  • Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N. Engl. J. Med.362, 27–35 (2010).
  • Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect. Dis.8(1), 44–52 (2008).
  • Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am. J. Epidemiol.148(11), 1094–1102 (1998).
  • Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit. Care Med.33(10 Suppl.), S390–S397 (2005).
  • Jamieson DJ, Theiler RN, Rasmussen SA. Emerging infections and pregnancy. Emerg. Infect. Dis.12(11), 1638–1643 (2006).
  • Saleeby E, Chapman J, Morse J, Bryant A. H1N1 influenza in pregnancy: cause for concern. Obstet. Gynecol.114(4), 885–891 (2009).
  • Hartert TV, Neuzil KM, Shintani AK et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am. J. Obstet. Gynecol.189(6), 1705–1712 (2003).
  • Dodds L, McNeil SA, Fell DB et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ176(4), 463–468 (2007).
  • Schanzer DL, Langley JM, Tam TW. Influenza-attributed hospitalization rates among pregnant women in Canada 1994–2000. J. Obstet. Gynaecol. Can.29(8), 622–629 (2007).
  • Harris JW. Influenza occurring in pregnant women. JAMA72(14), 978–980 (1919).
  • Centers for Disease Control and Prevention (CDC). Novel influenza A (H1N1) virus infection in three pregnant women – United States, April–May 2009. MMWR Morb. Mortal. Wkly Rep.58, 497–500 (2009).
  • Nuzum JW, Pilot I, Stangl FH, Bonar BE. 1918 pandemic influenza and pneumonia in a large civil hospital. IMJ Ill. Med. J.150(6), 612–616 (1976).
  • Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am. J. Obstet. Gynecol.78, 1172–1175 (1959).
  • Irwing WL, James DK, Stephenson T et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG107(10), 1282–1289 (2000).
  • Acs N, Banhidy F, Puho E, Czeizel AE. Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res. A Clin. Mol. Teratol.73(12), 989–996 (2005).
  • Gu J, Xie Z, Gao Z et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet370(9593), 1137–1145 (2007).
  • Zou S. Potential impact of pandemic influenza on blood safety and availability. Transfus. Med. Rev.20(3), 181–189 (2006).
  • Coffey VP, Jessop WJ. Maternal influenza and congenital deformities. A follow-up study. Lancet1(7284), 748–751 (1963).
  • Hardy JM, Azarozicz EN, Mannini A, Medearis DN, Cooke RE. The effect of Asian influenza on the outcome of pregnancy. Baltimore 1957–1958. Am. J. Public Health Nations Health51, 1182–1188 (1961).
  • Saxen L, Hjelt L, Sjostedt JE, Hakosalo J, Hakosalo H. Asian influenza during pregnancy and congenital malformations. Acta. Pathol. Microbiol. Scand.49, 114–126 (1960).
  • Doll R, Hill AB, Sakula J. Asian influenza in pregnancy and congenital defects. Br. J. Prev. Soc. Med.14, 167–172 (1960).
  • Shi L, Tu N, Patterson PH. Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. Int. J. Dev. Neurosci.23(2–3), 299–305 (2005).
  • Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology16(2), 16–19 (2005).
  • Wilson MG, Stein AM. Teratogenic effects of Asian influenza. An extended study. JAMA210(2), 336–337 (1969).
  • Edwards MJ. Review: hyperthermia and fever during pregnancy. Birth Defects Res. A Clin. Mol. Teratol.76(7), 507–516 (2006).
  • Kwan ML, Metayer C, Crouse V, Buffler PA. Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring. Am. J. Epidemiol.165(1), 27–35 (2007).
  • Takahashi M, Yamada T. A possible role of influenza A virus infection for Parkinson’s disease. Adv. Neurol.86, 91–104 (2001).
  • Deinard AS, Ogburn P. A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. Am. J. Obstet. Gynecol.140(3), 240–245 (1981).
  • Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J. Infect. Dis.140(2), 141–146 (1979).
  • Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J. Infect. Dis.168(3), 647–656 (1993).
  • Hulka JF. Effectiveness of polyvalent influenza vaccine in pregnancy: report of a controlled study during an outbreak of Asian influenza. Obstet. Gynecol.23, 830–837 (1964).
  • Murray DL, Imagawa DT, Okada DM, St Geme JW. Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women. J. Clin. Microbiol.10(2), 184–187 (1979).
  • Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med.359(15), 1555–1564 (2008).
  • Munoz FM, Greisinger AJ, Wehmanen OA et al. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol.192(4), 1098–1106 (2005).
  • Black SB, Shinefeld HR, France EK, Fireman BH, Platt ST, Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am. J. Perinatol.21(6), 333–339 (2004).
  • Steinhoff MC, Omer SB, Roy E et al. Influenza immunization in pregnancy is associated with increased birth weight: a randomized controlled trial. Presented at: 47th Annual Meeting of the Infectious Diseases Society of America. Philadelphia, PA, USA, 31 October 2009 (Poster #110).
  • Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J. Infect. Dis.142(6), 844–849 (1980).
  • France EK, Smith-Ray R, McClure D et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch. Pediatr. Adolesc. Med.160(12), 1277–1283 (2006).
  • Yeager DP, Toy EC, Baker B. Influenza vaccination in pregnancy. Am. J. Perinatol.16(6), 283–286 (1999).
  • Heinonen OP, Shapiro S, Monson RR, Hartz SC, Rosenberg L, Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int. J. Epidemiol.2(3), 229–235 (1973).
  • Heinonen OP, Slone D, Shapiro S. The collaborative perinatal project. In: Birth Defects and Drugs in Pregnancy. Kaufman DW (Ed.). Littleton Publishing Sciences Group, MA, USA, 314–321 (1977).
  • MacDonald NE, Riley LE, Steinhoff MC. Influenza immunization in pregnancy. Obstet. Gynecol.114(2), 365–368 (2009).
  • Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol.201(6), 547–552 (2009).
  • Pool V, Iskander J. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol.194(4), 1200 (2006).
  • Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. Mercury concentrations and metabolism in infants receiving vaccines containing thimerosal: a descriptive study. Lancet360, 1737–1741 (2002).
  • Henderson DC. Mercury in vaccines – reassuring news. Lancet360, 1711–1712 (2002).
  • Thompson WW, Price C, Goodson B et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N. Engl. J. Med.357, 1281–1292 (2007).
  • Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Autism and thimerosal containing vaccines: lack of consistent evidence for an association. Am. J. Prev. Med.25, 101–106 (2003).
  • Madsen KM, Lauritsen MB, Pedersen CB et al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics112, 604–606 (2003).
  • Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics118, e139–e150 (2006).
  • Verstraeten T, Davis RL, DeStefano F et al. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics112, 1039–1048 (2003).
  • Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. JAMA290, 1763–1766 (2003).
  • Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics114, 584–591 (2004).
  • Heron J, Golding J; ALSPAC Study Team. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics114, 577–583 (2004).
  • Fiore AE, Shay DK, Broder K et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2009. MMWR Recomm. Rep.58(RR-8), 1–52 (2009).
  • National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep.58(RR-10), 1–8 (2009).
  • Bridges CB, Thompson WW, Meltzer MI et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA284(13), 1655–1663 (2000).
  • Nichol KL, Lind A, Margolis KL et al. The effectiveness of vaccination against influenza in healthy, working adults. N. Engl. J. Med.333(14), 889–893 (1995).
  • Roberts S, Hollier LM, Sheffield J, Laibl V, Wendel GD. Cost–effectiveness of universal influenza vaccination in a pregnant population. Obstet. Gynecol.107(6), 1323–1329 (2006).
  • Beigi RH, Wiringa AE, Bailey RR, Assi TM, Lee BY. Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin. Infect. Dis.49(12), 1784–1792 (2009).
  • National Advisory Committee of Immunization (NACI). Statement on influenza vaccination for the 2008–2009 season. An Advisory Committee Statement. Can. Commun. Dis. Rep.34(ACS-3), 1–46 (2008).
  • Department of Health. Chapter 19: Influenza. In: Immunisation Against Infectious Disease – “The Green Book” (3rd Edition). Salisbury D, Ramsay M, Noakes K (Eds). London, UK, 185–200 (2006).
  • Gonik B, Jones T, Contreras D, Fasano N, Roberts C. The obstetrician – gynecologist’s role in vaccine-preventable diseases and immunization. Obstet. Gynecol.96(1), 81–84 (2000).
  • Yudin MH, Salaripour M, Sgro MD. Pregnant women’s knowledge of influenza and the use and safety of the influenza vaccine during pregnancy. J. Obstet. Gynaecol. Can.31(2), 120–125 (2009).
  • Center for Disease Control and Prevention. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage – United States, October–December 2009. MMWR Morb. Mortal. Wkly Rep.59(2), 44–48 (2010).
  • Centers for Disease Control and Prevention (CDC). Intent to receive influenza A (H1N1) 2009 monovalent and seasonal influenza vaccines – two counties, North Carolina, August 2009. MMWR Morb. Mortal. Wkly Rep.58(50), 1401–1405 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.